🇺🇸 FDA
Pipeline program

Albuterol eMDPI DS

21-0273

Unknown other completed

Quick answer

Albuterol eMDPI DS for Pulmonary Disease, Chronic Obstructive is a Unknown program (other) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Teva Pharma GmbH
Indication
Pulmonary Disease, Chronic Obstructive
Phase
Unknown
Modality
other
Status
completed

Clinical trials